Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma

Figure 9 High expression of Rho GTPase activating protein 12 under tyrosine kinase inhibitors treatment. A: Forest plot showing elevated expression of Rho GTPase activating protein 12; B: Summary receiver operating characteristic curve plot. SMD: Standardized mean difference; CI: Confidence interval; sROC: Summary receiver operating characteristic; AUC: Area under the receiver operating characteristic curve.